Inhibition of glucose-stimulated insulin release by α2-adrenoceptor activation is parallelled by both a repolarization and a reduction in cytoplasmic free Ca2+ concentration

T. Nilsson, P. Arkhammar, P. Rorsman, P. O. Berggren

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Effects of the α2-adrenergic agonist clonidine on insulin release, membrane potential, and cytoplasmic free Ca2+ concentration ([Ca2+](i)) were investigated using pancreatic β-cells isolated from obese hyperglycemic mice. Addition of 2 μM clonidine promptly inhibited glucose-stimulated insulin release, an effect accompanied by a lowering in both membrane potential and [Ca2+](i). Within minutes, the effect on Ca2+ was partly reversed, [Ca2+](i) attaining a new level, although still significantly lower than in the absence of agonist. This late increase in [Ca2+](i) was inhibited by 50 μM D-600, a blocker of voltage-activated Ca2+ channels. The inhibitory effects of clonidine on membrane potential, [Ca2+](i), and insulin release were abolished by 5 μM of the α2-adrenergic antagonist yohimbine. Depolarization with high K+ increased [Ca2+](i) also in the presence of clonidine, conditions accompanied by only a minute release of insulin. Secretion was, however, partly restored by subsequent addition of 20 mM glucose. Addition of 5 mM Ca2+ transiently reversed the effects of clonidine on both membrane potential and [Ca2+](i). Although the clonidine-induced repolarization should be enough for closing the voltage-activated Ca2+ channels with a resulting decrease in [Ca2+](i), a direct interaction of the agonist with these channels cannot be excluded. The fact that it was possible to increase [Ca2+](i) with only a minor effect on insulin release suggests that the inhibitory effect of clonidine not only is due to a reduction in [Ca2+](i), but also involves interference with some more distal step in the insulin secretory machinery.

Original languageEnglish
Pages (from-to)1855-1860
Number of pages6
JournalJournal of Biological Chemistry
Volume263
Issue number4
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Clonidine
Adrenergic Receptors
Chemical activation
Insulin
Glucose
Membrane Potentials
Membranes
Obese Mice
Gallopamil
Adrenergic Agonists
Adrenergic Antagonists
Yohimbine
Depolarization
Electric potential
Machinery

ASJC Scopus subject areas

  • Biochemistry

Cite this

Inhibition of glucose-stimulated insulin release by α2-adrenoceptor activation is parallelled by both a repolarization and a reduction in cytoplasmic free Ca2+ concentration. / Nilsson, T.; Arkhammar, P.; Rorsman, P.; Berggren, P. O.

In: Journal of Biological Chemistry, Vol. 263, No. 4, 01.01.1988, p. 1855-1860.

Research output: Contribution to journalArticle

@article{980c92d801a9416894e98cf344f2edc3,
title = "Inhibition of glucose-stimulated insulin release by α2-adrenoceptor activation is parallelled by both a repolarization and a reduction in cytoplasmic free Ca2+ concentration",
abstract = "Effects of the α2-adrenergic agonist clonidine on insulin release, membrane potential, and cytoplasmic free Ca2+ concentration ([Ca2+](i)) were investigated using pancreatic β-cells isolated from obese hyperglycemic mice. Addition of 2 μM clonidine promptly inhibited glucose-stimulated insulin release, an effect accompanied by a lowering in both membrane potential and [Ca2+](i). Within minutes, the effect on Ca2+ was partly reversed, [Ca2+](i) attaining a new level, although still significantly lower than in the absence of agonist. This late increase in [Ca2+](i) was inhibited by 50 μM D-600, a blocker of voltage-activated Ca2+ channels. The inhibitory effects of clonidine on membrane potential, [Ca2+](i), and insulin release were abolished by 5 μM of the α2-adrenergic antagonist yohimbine. Depolarization with high K+ increased [Ca2+](i) also in the presence of clonidine, conditions accompanied by only a minute release of insulin. Secretion was, however, partly restored by subsequent addition of 20 mM glucose. Addition of 5 mM Ca2+ transiently reversed the effects of clonidine on both membrane potential and [Ca2+](i). Although the clonidine-induced repolarization should be enough for closing the voltage-activated Ca2+ channels with a resulting decrease in [Ca2+](i), a direct interaction of the agonist with these channels cannot be excluded. The fact that it was possible to increase [Ca2+](i) with only a minor effect on insulin release suggests that the inhibitory effect of clonidine not only is due to a reduction in [Ca2+](i), but also involves interference with some more distal step in the insulin secretory machinery.",
author = "T. Nilsson and P. Arkhammar and P. Rorsman and Berggren, {P. O.}",
year = "1988",
month = "1",
day = "1",
language = "English",
volume = "263",
pages = "1855--1860",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "4",

}

TY - JOUR

T1 - Inhibition of glucose-stimulated insulin release by α2-adrenoceptor activation is parallelled by both a repolarization and a reduction in cytoplasmic free Ca2+ concentration

AU - Nilsson, T.

AU - Arkhammar, P.

AU - Rorsman, P.

AU - Berggren, P. O.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Effects of the α2-adrenergic agonist clonidine on insulin release, membrane potential, and cytoplasmic free Ca2+ concentration ([Ca2+](i)) were investigated using pancreatic β-cells isolated from obese hyperglycemic mice. Addition of 2 μM clonidine promptly inhibited glucose-stimulated insulin release, an effect accompanied by a lowering in both membrane potential and [Ca2+](i). Within minutes, the effect on Ca2+ was partly reversed, [Ca2+](i) attaining a new level, although still significantly lower than in the absence of agonist. This late increase in [Ca2+](i) was inhibited by 50 μM D-600, a blocker of voltage-activated Ca2+ channels. The inhibitory effects of clonidine on membrane potential, [Ca2+](i), and insulin release were abolished by 5 μM of the α2-adrenergic antagonist yohimbine. Depolarization with high K+ increased [Ca2+](i) also in the presence of clonidine, conditions accompanied by only a minute release of insulin. Secretion was, however, partly restored by subsequent addition of 20 mM glucose. Addition of 5 mM Ca2+ transiently reversed the effects of clonidine on both membrane potential and [Ca2+](i). Although the clonidine-induced repolarization should be enough for closing the voltage-activated Ca2+ channels with a resulting decrease in [Ca2+](i), a direct interaction of the agonist with these channels cannot be excluded. The fact that it was possible to increase [Ca2+](i) with only a minor effect on insulin release suggests that the inhibitory effect of clonidine not only is due to a reduction in [Ca2+](i), but also involves interference with some more distal step in the insulin secretory machinery.

AB - Effects of the α2-adrenergic agonist clonidine on insulin release, membrane potential, and cytoplasmic free Ca2+ concentration ([Ca2+](i)) were investigated using pancreatic β-cells isolated from obese hyperglycemic mice. Addition of 2 μM clonidine promptly inhibited glucose-stimulated insulin release, an effect accompanied by a lowering in both membrane potential and [Ca2+](i). Within minutes, the effect on Ca2+ was partly reversed, [Ca2+](i) attaining a new level, although still significantly lower than in the absence of agonist. This late increase in [Ca2+](i) was inhibited by 50 μM D-600, a blocker of voltage-activated Ca2+ channels. The inhibitory effects of clonidine on membrane potential, [Ca2+](i), and insulin release were abolished by 5 μM of the α2-adrenergic antagonist yohimbine. Depolarization with high K+ increased [Ca2+](i) also in the presence of clonidine, conditions accompanied by only a minute release of insulin. Secretion was, however, partly restored by subsequent addition of 20 mM glucose. Addition of 5 mM Ca2+ transiently reversed the effects of clonidine on both membrane potential and [Ca2+](i). Although the clonidine-induced repolarization should be enough for closing the voltage-activated Ca2+ channels with a resulting decrease in [Ca2+](i), a direct interaction of the agonist with these channels cannot be excluded. The fact that it was possible to increase [Ca2+](i) with only a minor effect on insulin release suggests that the inhibitory effect of clonidine not only is due to a reduction in [Ca2+](i), but also involves interference with some more distal step in the insulin secretory machinery.

UR - http://www.scopus.com/inward/record.url?scp=0023905926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023905926&partnerID=8YFLogxK

M3 - Article

C2 - 2892833

AN - SCOPUS:0023905926

VL - 263

SP - 1855

EP - 1860

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 4

ER -